Acute Effects of THC in Older Adult

Trial statusRecruiting
Trial phasePhase 1
Trial typeInterventional
Biological sexAll
Age21+
SponsorYale University

About this trial

The primary objective of this study is to determine if increasing age confers greater vulnerability to the acute A) cognitive (e.g., memory, attention, psychomotor function), B) subjective (e.g., anxiogenic and rewarding effects), and C) cardiovascular (heart rate and blood pressure), effects of THC in adults \> 21 years old. The secondary aims of the study are to explore age-related acute effects of THC on electrophysiological indices of information processing (e.g., auditory steady-state response (ASSR), oddball paradigm \[P300\], and resting state cortical noise) and to determine age-related differences in the metabolism of THC.

Eligibility criteria

Qualifiers

Ability to provide informed consent

No history (current or past) of unstable or serious medical, neurological or psychiatric conditions.

High school education or greater

No positive pregnancy test and/or lactation/ planning to nurse while in this study

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Delta-9-THC Low Dose
  • Placebo
  • Delta-9-THC Medium Dose

Treatment groups

60 Participants
are divided into 3 treatment groups

Sponsors and collaborators

Yale University

Lead sponsor

National Institute on Drug Abuse (NIDA)

Collaborator